Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has a cash flow conversion efficiency ratio of -0.018x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-91.95K) by net assets ($4.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hong Kong Pharma Digital Technology Hold balance sheet quality to measure how much of total assets are equity-financed.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hong Kong Pharma Digital Technology Hold cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anagenics Ltd
AU:AN1
|
-0.286x |
|
Tianci International, Inc. Common Stock
NASDAQ:CIIT
|
-0.002x |
|
Samchai Steel Industries Public Company Limited
BK:SAM
|
-0.061x |
|
Moolec Science SA Ordinary Shares
NASDAQ:MLEC
|
-0.318x |
|
Hansa Investment Company Ltd
LSE:HANA
|
0.020x |
|
Astrotech Corp
NASDAQ:ASTC
|
-0.228x |
|
IMPRENDIROMA S.P.A.
F:Y37
|
N/A |
|
Tantech Holdings Ltd
NASDAQ:TANH
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)
The table below shows the annual cash flow conversion efficiency of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Hong Kong Pharma Digital Technology Hold.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $4.99 Million | $569.21K | 0.114x | +223.05% |
| 2024-03-31 | $4.25 Million | $-394.33K | -0.093x | -103.14% |
| 2023-03-31 | $585.24K | $1.73 Million | 2.951x | -- |
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The comp… Read more